An observational study in IgA Nephropathy, sponsored by Guangdong Provincial People's Hospital. Completed at 1 site in China. Open to participants aged 14 Years to 80 Years. Per ClinicalTrials.gov, last updated 2015-08-19.
Sponsored by Guangdong Provincial People's Hospital · Observational
This is a survey of factors which affect a pathologically defined early or delayed diagnosis of IgA nephropathy in Guangdong General Hospital, Guangzhou, China. An early or delayed diagnosis of IgA nephropathy is pathologically defined using the recently published Oxford classification of IgA nephropathy. The factors to be surveyed include health examination including urine test, socioeconomic status of patients including education,etc.
262 studies on the registry are indexed under Glomerulonephritis, IGA; 102 are open to participants now.
This study's enrollment of 603 is above the median of 200 across 41 observational studies indexed under Glomerulonephritis, IGA.
Browse Glomerulonephritis, IGA studies →Guangdong Provincial People's Hospital is the lead sponsor of 237 studies on the registry; 102 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The consecutive biopsy-proven IgAN patients in Guangdong General Hospital, Guangzhou,China
Inclusion Criteria:
Factors potentially affecting an early or delayed diagnosis of IgA Nephropathy
Time frame: Before the biopsy
Glomerular filtration rate(GFR) decline rate or reaching end-stage renal disease (ESRD) or doubling of serum creatinine
Time frame: after the biopsy
This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Guangdong Provincial People's Hospital →